…
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized…
…
Predictors of Quality of Life and Other Patient-Reported Outcomes in the PANORAMA Multinational Study of People With Type 2 Diabetes
…
SCP4: A Small Nuclear Phosphatase Having a Big Effect on FoxOs in Gluconeogenesis
…
The Adiponectin Paradox for All-Cause and Cardiovascular Mortality
…
Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity
…
Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication
…
Which Costs More: Individualized Blood Sugar Management or Standard Care?
…
Severity of Neuropathy Is Associated With Long-term Spinal Cord Stimulation Outcome in Painful Diabetic Peripheral Neuropathy: Five-Year Follow-up of…
…
Admelog: Sanofi’s Fast Acting Insulin Lispro is FDA Approved
…
